Ellie’s Law
- Sponsor
- Sen. Blumenthal, Richard [D-CT]
- Committees
- Health, Education, Labor, and Pensions Committee (primary)
- Last action
- May 6, 2025
Bottom line
This bill aims to significantly boost federal funding for targeted research into unruptured intracranial aneurysms, with an emphasis on diverse patient demographics, to improve understanding and treatment of this life-threatening condition.
What it actually does
This bill authorizes the appropriation of $10,000,000 annually for fiscal years 2026 through 2030 to the National Institute of Neurological Disorders and Stroke (NINDS). These funds are specifically designated for comprehensive research on unruptured intracranial aneurysms, with a mandate to study a patient population diversified by age, sex, and race. The funding is intended to supplement, not supplant, existing research efforts.
Proponents argue
Supporters emphasize the critical need for increased research funding given that millions of Americans have unruptured brain aneurysms and tens of thousands suffer fatal ruptures annually, often with permanent neurological deficits for survivors. They highlight the disproportionate impact on women and certain racial groups, arguing that current federal spending on brain aneurysm research is insufficient and that dedicated funding is essential to prevent tragic outcomes and reduce the significant societal and fiscal burden of this condition.
Opponents contend
No direct opposition is typically raised against increased medical research funding for serious health conditions. However, potential critics might raise concerns about the allocation of research funds, suggesting that a specific authorization for one disease could potentially divert resources or attention from other critical neurological research areas, or that existing, broader funding mechanisms for the National Institutes of Health are sufficient to address such needs without specific earmarks.
The bill is exceptionally short and clearly written, allowing for a complete understanding of its provisions in a very brief reading time.
Section 3
Authorization of Appropriations for Unruptured Intracranial Aneurysm Research
This section authorizes the appropriation of $10,000,000 for each of fiscal years 2026 through 2030 to the National Institute of Neurological Disorders and Stroke (NINDS). These funds are specifically for conducting or supporting further comprehensive research on unruptured intracranial aneurysms. The bill explicitly mandates that this research study a broader patient population diversified by age, sex, and race, and clarifies that these funds are to supplement, not replace, other existing funding for brain aneurysm research.
Supporters argue
Supporters argue that this dedicated funding is essential to address the severe public health threat posed by brain aneurysms, which are currently under-researched relative to their prevalence and impact. They highlight the importance of mandating research across diverse demographics to ensure that advancements benefit all affected populations, especially given documented disparities in rupture rates.
Critics contend
No specific opposition is typically raised against this provision, as it addresses a serious health condition with a relatively modest funding request. Any potential concerns might center on the principle of earmarking funds for specific diseases rather than allowing scientific agencies full discretion in allocating research dollars based on evolving scientific priorities and peer review.
Tradeoffs
The primary tension involves balancing the need for targeted research on specific diseases with the broader principle of allowing scientific agencies flexibility in allocating research funds. While this bill ensures attention to brain aneurysms, it represents a specific legislative directive that some might argue could set a precedent for other disease-specific funding mandates, potentially fragmenting the overall research budget.